QT
MXCT icon

Quantbot Technologies’s MaxCyte MXCT Stock Holding History

Quantbot Technologies’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-153
Closed -$477 – 1849
2023
Q3 		$477 Buy
+153
New +$615 ﹤0.01% 1482
2022
Q3 		– Sell
-5,782
Closed -$27K – 1908
2022
Q2 		$27K Buy
+5,782
New +$28.5K ﹤0.01% 1416

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's MXCT Position: Q4 2023 in Review

Quantbot Technologies sold out of MaxCyte (MXCT) in Q4 2023, closing a stake of 153 shares — an estimated $477 sold.

Quantbot Technologies first reported a position in MXCT in Q2 2022 and held it in 2 quarters. The position peaked at $27K in Q2 2022. 120 funds tracked by Wall St. Rank hold MXCT as of Q4 2023.

  • Quantbot Technologies reported no remaining MaxCyte position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 153 MaxCyte shares in Q4 2023, an estimated $477.
  • Quantbot Technologies first reported a position in MaxCyte in Q2 2022 and held it in 2 quarters.
  • Quantbot Technologies's MaxCyte position peaked at $27K in Q2 2022.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.